MedTrace Logo

InvesT1D: Promoting Adolescent Investment in Diabetes Care

NCT06384911 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2025-12-16

No results posted yet for this study

Summary

The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes.

Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.

Conditions

Interventions

BEHAVIORAL

Financial Incentives Program

Adolescent participants will receive financial incentives for meeting diabetes self-management and clinical outcome goals.

Sponsors & Collaborators

  • Seattle Children's Hospital

    collaborator OTHER

  • Harvard Pilgrim Health Care

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-25
Primary Completion
2027-07-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06384911 on ClinicalTrials.gov